Error loading HTML
Class Action Lawsuit Headlines
-
Settlement: Real Estate – Verdict in favor of Plaintiff in the amount of US$30,023
-
Settlement: Defective Products – Verdict in favor of Plaintiff in the amount of US$7,500,000
Error loading HTML
-
Settlement: Accidents – Verdict in favor of Plaintiff in the amount of US$5,000,000
Error loading HTML
-
Potential Lawsuit: Injectafer Lawsuit News and Legal Information
Injectafer (ferric carboxymaltose) is an intravenous iron replacement medication prescribed to adult patients for the treatment of iron deficiency anemia. Research indicates that patients taking the iron replacement product are at high risk of developing hypophosphatemia (HPP), a condition that can be life-threatening. Injectafer lawsuits allege that consumers and the medical community were not adequately warned of Injectafer HPP risk and other adverse side effects.
-
Lawsuit Filed: Utah Medical Malpractice Lawsuit News & Legal Information
Utah medical malpractice claims are essentially negligence claims made against doctors, hospitals or other healthcare professionals or organizations. They cover missteps like delaying treatment, giving the wrong medicine, using a defective medical device, failing to deliver a baby on time, or even just neglecting to give the patient enough information to make a reasonable medical decision. These are only a few of the reasons patients or their families may file Utah medical malpractice lawsuits.
-
Potential Lawsuit: Paragard IUD Lawsuit News and Legal Information
Paragard IUD lawsuits are now in the early stages of multidistrict litigation (MDL) consolidation in Philadelphia and more lawsuits are under investigation. Melissa Arias’s story about her experience with her Paragard T 380A is sadly commonplace.
-
Settlement: oalition of 24 State Attorneys General Announces over $550 Million Settlements with Nation’s Largest Subprime Autho Financing Company
Settlement with Santander Includes more than $550 Million in Relief for Consumers
-
Potential Lawsuit: Elmiron Vision Loss Lawsuit news and Legal Information
Elmiron (pentosan polysulfate sodium), a drug widely prescribed for a bladder condition, has been associated with eye damage. Hundreds of thousands of people who have taken Elmiron may have been exposed to the risk of potentially permanent vision damage. Recent studies suggest that Elmiron is toxic to the retina, and one study shows that about 25 percent of patients with significant exposure to the drug show signs of retinal damage. As a result of these studies, vision loss lawsuits have been filed against Janssen Pharmaceuticals for failing to properly warn the public about the risk of vision problems.